Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175042 · ClinicalTrials.gov registry record
Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic
A clinical trial of Anemia in Pregnancy, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT03175042 is a study of Anemia in Pregnancy that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03175042, a study of Anemia in Pregnancy, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Pregnant patients in the UT Medical Branch outpatient obstetric clinic are screened for anemia via blood draw at first prenatal visit. Those who meet Center for Disease Control (CDC) criteria for anemia during pregnancy (hemoglobin less than 11g/dL in first and third trimesters and hemoglobin less than 10.5g/dL during the second trimester), will be approached for participation in this study. It is the protocol of the UT Medical Branch outpatient obstetric clinic to repeat a blood draw every 4 weeks in patients with anemia. At the time of their blood draw, patients who participate in our study will have the Masimo Spot Non-invasive Hemoglobin monitor placed on our finger. The primary aim of the study is to see how accurate the non-invasive monitor is compared with blood draw. With the potential benefit being earlier diagnosis of anemia and easier method to ensure improvement in the hemoglobin.
Conditions Studied
Interventions
- DEVICE Masimo spot hemoglobin non-invasive monitor
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03175042
The ClinicalTrials.gov registry entry for NCT03175042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia in Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Masimo spot hemoglobin non-invasive monitor is the first listed.
NCT03175042 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03175042 about?
NCT03175042 is a clinical study titled "Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic". Pregnant patients in the UT Medical Branch outpatient obstetric clinic are screened for anemia via blood draw at first prenatal visit. Those who meet Center for Disease Control (CDC) criteria for anemia during pregnancy (hemoglobin less than 11g/dL in first and third trimesters and hemoglobin less t...
What is the current status of trial NCT03175042?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-06-13. Estimated completion is 2017-12-31.
What conditions does trial NCT03175042 study?
This clinical trial studies the following conditions: Anemia in Pregnancy.
What interventions are being tested in trial NCT03175042?
The interventions under investigation include: Masimo spot hemoglobin non-invasive monitor (DEVICE).
Who is sponsoring clinical trial NCT03175042?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03175042 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.